Timothy E. Wilens

1.7k total citations
30 papers, 1.2k citations indexed

About

Timothy E. Wilens is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Pharmacology. According to data from OpenAlex, Timothy E. Wilens has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Psychiatry and Mental health, 9 papers in Cognitive Neuroscience and 6 papers in Pharmacology. Recurrent topics in Timothy E. Wilens's work include Attention Deficit Hyperactivity Disorder (22 papers), Child and Adolescent Psychosocial and Emotional Development (5 papers) and Bipolar Disorder and Treatment (5 papers). Timothy E. Wilens is often cited by papers focused on Attention Deficit Hyperactivity Disorder (22 papers), Child and Adolescent Psychosocial and Emotional Development (5 papers) and Bipolar Disorder and Treatment (5 papers). Timothy E. Wilens collaborates with scholars based in United States, United Kingdom and Australia. Timothy E. Wilens's co-authors include Thomas Spencer, Stephen V. Faraone, Eric Mick, JOSEPH BIEDERMAN, Joseph Biederman, Thomas Spencer, J Biederman, Annah N. Abrams, Himanshu P. Upadhyaya and Jefferson B. Prince and has published in prestigious journals such as New England Journal of Medicine, JAMA and American Journal of Psychiatry.

In The Last Decade

Timothy E. Wilens

27 papers receiving 1.2k citations

Peers

Timothy E. Wilens
Elizabeth P. Sparrow United States
Thomas Spencer United States
Maria Gasior United States
Nancy Lockhart United States
Luca Tessari United Kingdom
Humberto Quintana United States
Nicoletta Adamo United Kingdom
Elizabeth P. Sparrow United States
Timothy E. Wilens
Citations per year, relative to Timothy E. Wilens Timothy E. Wilens (= 1×) peers Elizabeth P. Sparrow

Countries citing papers authored by Timothy E. Wilens

Since Specialization
Citations

This map shows the geographic impact of Timothy E. Wilens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy E. Wilens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy E. Wilens more than expected).

Fields of papers citing papers by Timothy E. Wilens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy E. Wilens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy E. Wilens. The network helps show where Timothy E. Wilens may publish in the future.

Co-authorship network of co-authors of Timothy E. Wilens

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy E. Wilens. A scholar is included among the top collaborators of Timothy E. Wilens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy E. Wilens. Timothy E. Wilens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schepis, Ty S., et al.. (2025). Severity of stimulant use disorder by psychostimulant type and polystimulant use pattern.. Experimental and Clinical Psychopharmacology. 33(3). 275–284.
2.
McCabe, Sean Esteban, et al.. (2025). Attention-Deficit/Hyperactivity Disorder Symptoms and Later E-Cigarette and Tobacco Use in US Youths. JAMA Network Open. 8(2). e2458834–e2458834. 2 indexed citations
3.
McCabe, Sean Esteban, Timothy E. Wilens, Ty S. Schepis, et al.. (2025). Trends in Prescription Stimulant, Opioid, and Benzodiazepine Use and Diversion in U.S. Adolescents. American Journal of Psychiatry. 182(7). 683–687.
4.
McCabe, Sean Esteban, et al.. (2025). Trends in Medical and Nonmedical Use of Prescription Stimulants Among US Adolescents. JAMA. 334(12). 1110–1110.
5.
Baweja, Raman, Aditya Pawar, James G. Waxmonsky, & Timothy E. Wilens. (2025). Management of Attention-Deficit/Hyperactivity Disorder in Transitional-Aged Youth With Comorbid Substance Use Disorder. Psychiatric Annals. 55(10). 1 indexed citations
6.
Anderson, Thomas A., et al.. (2017). To Stop or Not, That Is the Question. Anesthesiology. 126(6). 1180–1186. 90 indexed citations
7.
Wilens, Timothy E., Michael L. Vitulano, Himanshu P. Upadhyaya, et al.. (2008). Cigarette Smoking Associated with Attention Deficit Hyperactivity Disorder. The Journal of Pediatrics. 153(3). 414–419.e1. 80 indexed citations
8.
Wilens, Timothy E.. (2007). ADHD: Prevalence, Diagnosis, and Issues of Comorbidity. CNS Spectrums. 12(S6). 1–5. 7 indexed citations
9.
McGough, James J., Keith McBurnett, Oscar G. Bukstein, et al.. (2006). Once-Daily OROS ® Methylphenidate Is Safe and Well Tolerated in Adolescents With Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 16(3). 351–356. 31 indexed citations
10.
Wilens, Timothy E., et al.. (2002). Fluoxetine Pharmacokinetics in Pediatric Patients. Journal of Clinical Psychopharmacology. 22(6). 568–575. 45 indexed citations
11.
Faraone, Stephen V., JOSEPH BIEDERMAN, Eric Mick, et al.. (2001). A family study of psychiatric comorbidity in girls and boys with attention-deficit/hyperactivity disorder. Biological Psychiatry. 50(8). 586–592. 49 indexed citations
12.
Spencer, Thomas, Joseph Biederman, John H. Heiligenstein, et al.. (2001). An Open-Label, Dose-Ranging Study of Atomoxetine in Children with Attention Deficit Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 11(3). 251–265. 120 indexed citations
13.
Faraone, Stephen V., J Biederman, Eric Mick, et al.. (2000). Family Study of Girls With Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry. 157(7). 1077–1083. 109 indexed citations
14.
Cohen, Louise Glassner, Joseph Biederman, Timothy E. Wilens, et al.. (1999). Desipramine Clearance in Children and Adolescents: Absence of Effect of Development and Gender. Journal of the American Academy of Child & Adolescent Psychiatry. 38(1). 79–85. 12 indexed citations
15.
Wilens, Timothy E. & Thomas Spencer. (1999). Combining Methylphenidate and Clonidine: A CLINICALLY SOUND MEDICATION OPTION. Journal of the American Academy of Child & Adolescent Psychiatry. 38(5). 614–616. 66 indexed citations
16.
Wilens, Timothy E., J Biederman, Horace J. Spencer, et al.. (1999). A Pilot Controlled Clinical Trial of ABT-418, a Cholinergic Agonist, in the Treatment of Adults With Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry. 156(12). 1931–1937. 182 indexed citations
17.
Wilens, Timothy E., et al.. (1998). THE USE OF TRICYCLIC ANTIDEPRESSANTS IN CHILDREN AND ADOLESCENTS. Pediatric Clinics of North America. 45(5). 1123–1135. 38 indexed citations
18.
Wilens, Timothy E., JOSEPH BIEDERMAN, Ana M. Abrantes, & Thomas Spencer. (1996). A Naturalistic Assessment of Protriptyline for Attention-Deficit Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 35(11). 1485–1490. 18 indexed citations
19.
BIEDERMAN, JOSEPH, et al.. (1994). Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Research. 53(1). 13–29. 228 indexed citations
20.
Wilens, Timothy E.. (1994). A Practitioner's Guide to Psychoactive Drugs for Children and Adolescents. Journal of the American Academy of Child & Adolescent Psychiatry. 33(8). 1213–1214. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026